Kaehler, K. C., Ziemer, M., Hassel, J. C., Rutkowski, P., Meier, F. E., Flatz, L., Gaudy-Marqueste, C., Santinami, M., Russano, F., Wasielewski, I. V., Eigentler, T., Maio, M., Zalaudek, I., Haferkamp, S., Quaglino, P., Welzel, J., Ascierto, P. A., Robert, C., Schadendorf, D., Hauschild, A. (2026). Neoadjuvant intralesional daromun (L19IL2/L19TNF) in resectable locally advanced melanoma: An update on the primary outcome and sensitivity analyses (EFS) from the PIVOTAL phase 3 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba9517